CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $380,000 | +10.5% | 105,197 | +8.1% | 0.00% | 0.0% |
| Q4 2016 | $344,000 | -33.6% | 97,299 | -24.1% | 0.00% | -25.0% |
| Q3 2016 | $518,000 | -14.9% | 128,179 | -7.6% | 0.00% | -20.0% |
| Q2 2016 | $609,000 | +45.0% | 138,680 | +24.9% | 0.01% | +25.0% |
| Q1 2016 | $420,000 | -79.4% | 111,003 | -14.6% | 0.00% | -80.0% |
| Q4 2015 | $2,038,000 | -87.5% | 129,951 | -15.7% | 0.02% | +17.6% |
| Q3 2015 | $16,247,000 | +559.1% | 154,146 | +57.7% | 0.02% | -19.0% |
| Q2 2015 | $2,465,000 | +83.7% | 97,726 | +102.9% | 0.02% | +90.9% |
| Q1 2015 | $1,342,000 | – | 48,155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |